Onconova Therapeutics Inc. Forecast, price target & analysts
Onconova Therapeutics Inc. Target price 2024 - Analyst rating & recommendation
Onconova Therapeutics Inc. Classifications & Recommendation:
Onconova Therapeutics Inc. Price Target
| Target Price | $6.00 |
| Price | $13.42 |
| Deviation |
55.29%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Onconova Therapeutics Inc. price target 2025.
The average Onconova Therapeutics Inc. target price is $6.00.
This is
55.29%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend Onconova Therapeutics Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Onconova Therapeutics Inc. stock has an average upside potential 2025 of
55.29%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.23 | 0.23 |
| 0.00% | 0.00% | |
| Net Margin | -29,733.52% | -203,339.35% |
| 0.49% | 583.87% |
1 Analyst has issued a sales forecast Onconova Therapeutics Inc. 2024 . The average Onconova Therapeutics Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Onconova Therapeutics Inc. 2024 . The average Onconova Therapeutics Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -22.57 | -154.35 |
| 0.49% | 583.87% | |
| P/E | negative | |
| EV/Sales | 153.00 |
1 Analysts have issued a Onconova Therapeutics Inc. forecast for earnings per share. The average Onconova Therapeutics Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Onconova Therapeutics Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Onconova Therapeutics Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
